Strategic line 1 is called “The Human Genome” and focuses on the study of the fundamentals of the human genome and epigenome, as well as the development of tools for its manipulation. For this purpose, cutting-edge sequencing and data analysis technologies are used, including artificial intelligence algorithms.

The activity of the research groups in this strategic line makes GENyO an international reference in the knowledge of the biology of our genome, including complementary topics such as the genomics of complex diseases, regulation of transposable elements and the function of the epigenome during embryonic development and in human diseases.

Research Groups

Within the line dedicated to Human Genome research, we can find the following associated research groups: